|Titre :||Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting (2012)|
|Auteurs :||M. L. DRAINONI ; A. H. LITWIN ; B. D. SMITH ; E. A. KOPPELMAN ; M. D. McKEE ; C. L. CHRISTIANSEN ; A. L. GIFFORD ; C. M. WEINBAUM ; W. N. SOUTHERN|
|Type de document :||Article : Périodique|
|Dans :||American Journal of Public Health (Vol.102, n°11, November 2012)|
|Article en page(s) :||e115-e121|
|Note générale :||Analyse dans le Flyer n°53, p. 4-6|
|Discipline :||MAL (Maladies infectieuses / Infectious diseases)|
Thésaurus TOXIBASEHEPATITE ; DEPISTAGE ; POPULATION A RISQUE ; EFFICACITE ; FACTEUR DE RISQUE ; INJECTION ; VOIE NASALE ; QUESTIONNAIRE ; MEDECIN GENERALISTE
OBJECTIVES: We evaluated an intervention designed to identify patients at risk for hepatitis C virus (HCV) through a risk screener used by primary care providers.
METHODS: A clinical reminder sticker prompted physicians at 3 urban clinics to screen patients for 12 risk factors and order HCV testing if any risks were present. Risk factor data were collected from the sticker; demographic and testing data were extracted from electronic medical records. We used the t test, chi(2) test, and rank-sum test to compare patients who had and had not been screened and developed an analytic model to identify the incremental value of each element of the screener.
RESULTS: Among screened patients, 27.8% (n = 902) were identified as having at least 1 risk factor. Of screened patients with risk factors, 55.4% (n = 500) were tested for HCV. Our analysis showed that 7 elements (injection drug use, intranasal drug use, elevated alanine aminotransferase, transfusions before 1992, >= 20 lifetime sex partners, maternal HCV, existing liver disease) accounted for all HCV infections identified.
CONCLUSIONS: A brief risk screener with a paper-based clinical reminder was effective in increasing HCV testing in a primary care setting.
|Domaine :||Drogues illicites / Illicit drugs|
|Refs biblio. :||25|
|Affiliation :||Department of Health and Policy Management, Boston University School of Public Health, Boston, MA, USA|